Preschool meds: the first clinical trial examining the effects of generic Ritalin on 3- to 5-year-old subjects raises questions not only about the safety of the drug but also about the ethics of testing on ever younger brains.
Stolberg
Sheryl Gay
SG
D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D032763:Behavior Control; D000697:Central Nervous System Stimulants / Q000008:administration & dosage; D002652:Child Behavior / Q000187:drug effects; D002675:Child, Preschool; D002986:Clinical Trials as Topic / Q000941:ethics; D004348:Drug Labeling; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use*; D009315:National Institute of Mental Health (U.S.); D016487:Parenting; D018579:Patient Selection; D014481:United States
D000697:Central Nervous System Stimulants; D008774:Methylphenidate